Skip to main content

Month: April 2025

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry Events FREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) — Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcasing its patented Full Spectrum Profiling™ (FSP®) technology at CYTO 2025 and American Association of Immunologists’ (AAI) IMMUNOLOGY2025. Designed to streamline workflows, accelerate discoveries, and enhance efficiency, FSP technology will be the focus of a variety of demonstrations, educational workshops and tutorials at these prominent industry gatherings. Flow cytometry plays a crucial role in both research and clinical studies, and Cytek is at the forefront of making this powerful technology more accessible and scalable. By empowering scientists to accelerate discovery and...

Continue reading

Urgently Announces First Quarter 2025 Earnings Release Date and Conference Call; Participation in Upcoming Investor Conferences

VIENNA, Va., April 29, 2025 (GLOBE NEWSWIRE) — Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today announced the date for the release of its first quarter 2025 financial results and its participation in upcoming investor conferences. First Quarter 2025 Earnings Urgently will host a conference call on Tuesday, May 13, 2025, at 5:00 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2025. Financial results will be issued in a press release prior to the call. Those wishing to participate via webcast should access the call through Urgently’s Investor Relations website at https://investors.geturgently.com. Those wishing to participate via telephone may dial in at 1-877-317-6789 (USA) or 1-412-317-6789...

Continue reading

Urbanfund Corp. Announces Loan to Shareholder

TORONTO, April 29, 2025 (GLOBE NEWSWIRE) — Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), announces that it entered into loan agreement dated April 29, 2025 (the “Loan Agreement”) pursuant to which the Company has agreed to loan Westdale Construction Co. Limited (“Westdale”) the principal amount of ‎‎$3,000,000‎‎ (the “Loan”). The Loan is repayable on July 29th 2025 and will bear interest at ‎‎5.95% per annum. Westdale is a control person of the Company. The Company’s Chairman, Ronald Kimel, is a shareholder, director and officer of Westdale and Mitchell Cohen, the Company’s Chief Executive ‎Officer, is an officer‎ of Westdale. Accordingly, the Loan constitutes a “related party transaction” pursuant to Multilateral Instrument 61-101 – ‎Protection of ‎Minority Security Holders in Special Transactions (“MI 61-101”)....

Continue reading

ChampionX Reports First Quarter 2025 Results

THE WOODLANDS, Texas, April 29, 2025 (GLOBE NEWSWIRE) — ChampionX Corporation (NASDAQ: CHX) (“ChampionX” or the “Company”) today announced first quarter of 2025 results. Revenue was $864.5 million, net income attributable to ChampionX was $85.8 million, and adjusted EBITDA was $190.9 million. Income before income taxes margin was 12.1% and adjusted EBITDA margin was 22.1%. Cash from operating activities was $66.8 million and free cash flow was $38.6 million. CEO Commentary “The first quarter demonstrated the resilience of our ChampionX portfolio as we delivered strong adjusted EBITDA and adjusted EBITDA margin, and generated positive free cash flow. These results reflect the commitment of our ChampionX employees around the world who express daily an unwavering focus on delivering value-added solutions for our customers’ most important...

Continue reading

Sonoco Reports First Quarter 2025 Results

HARTSVILLE, S.C., April 29, 2025 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a core mid-cap growth and value equity which is a global leader in high-value sustainable packaging, today reported financial results for the first quarter ended March 30, 2025. References in today’s news release to consolidated “net sales,” “operating profit,” and “adjusted operating profit,” and Consumer Packaging segment “segment operating profit” and “segment adjusted EBITDA” along with the corresponding year-over-year comparable results, do not include results of the Company’s Thermoformed and Flexibles Packaging business and its global Trident business (collectively, “TFP”), which are being accounted for as discontinued operations. Summary:Completed $1.8 billion sale of TFP to TOPPAN Holdings Inc. on April...

Continue reading

Telesat Schedules First Quarter 2025 Earnings Conference Call for May 6, 2025

OTTAWA, Ontario, April 29, 2025 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, has scheduled a conference call on Tuesday, May 6, 2025, at 10:30 a.m. EDT to discuss its financial results for the three month period ended March 31, 2025. The call will be hosted by Daniel S. Goldberg, President and Chief Executive Officer, and Andrew Browne, Chief Financial Officer, of Telesat. Prior to the commencement of the call, Telesat will post a news release containing its financial results on its website (www.telesat.com) under the tab “Investors” and the heading “Investor News.” Dial-in Instructions: The toll-free dial-in number for the teleconference is +1-800-952-5114. Callers outside of North America should dial +1-416-406-0743. The access code is 5237299 followed...

Continue reading

TalentAlly and disABLEDperson Celebrate 10 Years of Partnership Empowering Job Seekers with Disabilities

CHICAGO, April 29, 2025 (GLOBE NEWSWIRE) — TalentAlly, a business unit of Professional Diversity Network, Inc. (NASDAQ: IPDN) and a leading provider of inclusive recruitment solutions and job board services in the United States, proudly celebrates the 10th anniversary of its partnership with disABLEDperson, Inc., one of the nation’s premier disability-focused job boards. Since forming the collaboration in 2014, TalentAlly and disABLEDperson have worked together to expand access to meaningful, rewarding employment opportunities for individuals with disabilities nationwide. As part of this longstanding commitment, TalentAlly actively promotes inclusive hiring through its dedicated platform, Ability Careers (www.abilitycareers.com), which has attracted nearly 20,000 users from the disability community over the past 12 months alone....

Continue reading

Kadant Reports First Quarter 2025 Results

WESTFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) reported its financial results for the first quarter ended March 29, 2025. First Quarter Financial HighlightsBookings increased 3% to $256 million Revenue decreased 4% to $239 million Gross margin increased 150 basis points to 46.1% Net income decreased 3% to $24 million GAAP EPS decreased 3% to $2.04 Adjusted EPS decreased 12% to $2.10 Adjusted EBITDA decreased 8% to $48 million and represented 20.0% of revenue Operating cash flow remained flat at $23 million Free cash flow increased 15% to $19 millionNote: Percent changes above are based on comparison to the prior year period. All references to earnings per share (EPS) are to our EPS as calculated on a diluted basis. Adjusted EPS, adjusted EBITDA, adjusted EBITDA margin, free cash flow, and changes...

Continue reading

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable safety profile, dose limiting toxicity dose level has not been identified in doses up to 250 mg/day Preclinical posters strengthen the NXP900 clinical development strategy as single agent in biomarker-targeted cancers and in combination with market leading therapies to overcome resistance in NSCLC Fort Lee, NJ, April 29, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology today provided poster presentation...

Continue reading

Silvaco Expands Product Offerings in Photonics and Wafer-Scale Plasma Modeling for AI Applications with Acquisition of Tech-X Corporation

SANTA CLARA, Calif., April 29, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced the strategic acquisition of Tech-X Corporation, a leading provider of multi-physics simulation software used in applications such as Photonics, Electromagnetics and Plasma Dynamics. Tech-X cutting-edge tools enable:Multi-physics simulation of electromagnetic, and electrostatics in complex dielectric and metallic environments; Combination of computational speed leveraging GPUs, and high-fidelity results for Photonics applications; Plasma Dynamics simulation trusted by engineers and researchers in aerospace and semiconductor manufacturing; and Monte...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.